ITMI20051630A1 - Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi - Google Patents
Formulazione farmaceutica sterile iniettabile contenente almeno due principi attiviInfo
- Publication number
- ITMI20051630A1 ITMI20051630A1 IT001630A ITMI20051630A ITMI20051630A1 IT MI20051630 A1 ITMI20051630 A1 IT MI20051630A1 IT 001630 A IT001630 A IT 001630A IT MI20051630 A ITMI20051630 A IT MI20051630A IT MI20051630 A1 ITMI20051630 A1 IT MI20051630A1
- Authority
- IT
- Italy
- Prior art keywords
- pharmaceutical formulation
- formulation containing
- active principles
- sterile pharmaceutical
- injectable sterile
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001630A ITMI20051630A1 (it) | 2005-09-02 | 2005-09-02 | Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi |
| US11/493,522 US7964589B2 (en) | 2005-09-02 | 2006-07-27 | Injectable sterile pharmaceutical formulation containing at least two active principles |
| JP2006205688A JP5060747B2 (ja) | 2005-09-02 | 2006-07-28 | 少なくとも2種の有効成分を含有する、注射可能無菌薬物配合物 |
| CA002554859A CA2554859A1 (en) | 2005-09-02 | 2006-07-31 | A process for preparing an injectable sterile pharmaceutical formulation containing at least piperacillin sodium and tazobactam sodium active principles |
| EP06118645A EP1759697A1 (en) | 2005-09-02 | 2006-08-09 | Pharmaceutical formulation containing at least two active principles |
| KR1020060083413A KR20070026187A (ko) | 2005-09-02 | 2006-08-31 | 2개 이상의 활성 물질을 함유하는 주사용 멸균 약제학적제형 |
| CN200610126685XA CN1923285B (zh) | 2005-09-02 | 2006-09-01 | 含有至少两种活性成分的注射用无菌药物制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001630A ITMI20051630A1 (it) | 2005-09-02 | 2005-09-02 | Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ITMI20051630A1 true ITMI20051630A1 (it) | 2007-03-03 |
Family
ID=37402634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT001630A ITMI20051630A1 (it) | 2005-09-02 | 2005-09-02 | Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7964589B2 (it) |
| EP (1) | EP1759697A1 (it) |
| JP (1) | JP5060747B2 (it) |
| KR (1) | KR20070026187A (it) |
| CN (1) | CN1923285B (it) |
| CA (1) | CA2554859A1 (it) |
| IT (1) | ITMI20051630A1 (it) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20070568A1 (it) * | 2007-03-22 | 2008-09-23 | Acs Dobfar Spa | Comosizione farmaceutica sterile iniettabile avente piperacillina sodica e tazobactam sodico come principi attivi |
| WO2013014544A1 (en) * | 2011-07-25 | 2013-01-31 | Vardhman Chemtech Limited | Method for preparation of composition of piperacillin sodium and tazobactam sodium |
| US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
| KR101816798B1 (ko) | 2012-10-19 | 2018-01-10 | 주식회사유한양행 | 피페라실린 또는 그의 염, 타조박탐 또는 그의 염 및 덱사메타손 포스페이트 또는 그의 염을 포함하는 국소투여용 약학 조성물 |
| EP2893929B1 (en) | 2013-03-15 | 2025-04-16 | Merck Sharp & Dohme LLC | Ceftolozane antibiotic compositions |
| US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
| US20140274997A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Cephalosporin pharmaceutical compositions |
| AU2014233637A1 (en) | 2013-09-09 | 2015-03-26 | Merck Sharp & Dohme Corp. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
| US20150094293A1 (en) | 2013-09-27 | 2015-04-02 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
| CN112409381B (zh) * | 2020-12-03 | 2022-03-01 | 山东安信制药有限公司 | 一种哌拉西林钠他唑巴坦钠共无定形物及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2925963A1 (de) * | 1979-06-27 | 1981-01-22 | Bayer Ag | Penicillin-1,1-dioxide, ihre herstellung und ihre verwendung als arzneimittel |
| US4477452A (en) * | 1981-03-26 | 1984-10-16 | American Cyanamid Company | Composition of matter comprising a lyophilized preparation of a penicillin derivative |
| CA1209477A (en) * | 1981-03-26 | 1986-08-12 | Bruce E. Haeger | Composition of matter comprising a lyophilized preparation of a penicillin derivative |
| CA1222691A (en) * | 1981-12-29 | 1987-06-09 | Wilhelmus T. Goedemans | Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments |
| JPS58135823A (ja) * | 1982-02-05 | 1983-08-12 | Chugai Pharmaceut Co Ltd | 抗生物質組成物およびその製法 |
| IT1255716B (it) * | 1992-10-05 | 1995-11-10 | Procedimento per la preparazione di antibiotici beta-lattamici sterili | |
| AU2003230899A1 (en) | 2003-04-14 | 2004-11-26 | Wyeth Holdings Corporation | Compositions containing piperacillin and tazobactam useful for injection |
| US6900184B2 (en) * | 2003-04-14 | 2005-05-31 | Wyeth Holdings Corporation | Compositions containing pipercillin and tazobactam useful for injection |
| PT1468697E (pt) * | 2003-04-14 | 2008-03-05 | Wyeth Corp | Composições contendo piperacilina e tazobactam úteis para injecção |
-
2005
- 2005-09-02 IT IT001630A patent/ITMI20051630A1/it unknown
-
2006
- 2006-07-27 US US11/493,522 patent/US7964589B2/en active Active
- 2006-07-28 JP JP2006205688A patent/JP5060747B2/ja not_active Expired - Fee Related
- 2006-07-31 CA CA002554859A patent/CA2554859A1/en not_active Abandoned
- 2006-08-09 EP EP06118645A patent/EP1759697A1/en not_active Withdrawn
- 2006-08-31 KR KR1020060083413A patent/KR20070026187A/ko not_active Ceased
- 2006-09-01 CN CN200610126685XA patent/CN1923285B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1923285B (zh) | 2010-06-23 |
| JP2007070341A (ja) | 2007-03-22 |
| US20070054889A1 (en) | 2007-03-08 |
| KR20070026187A (ko) | 2007-03-08 |
| CN1923285A (zh) | 2007-03-07 |
| JP5060747B2 (ja) | 2012-10-31 |
| CA2554859A1 (en) | 2007-03-02 |
| US7964589B2 (en) | 2011-06-21 |
| EP1759697A1 (en) | 2007-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2073795T3 (da) | Misbrugssikret lægemiddelformulation | |
| DK2346495T4 (da) | Farmaceutisk formulering 514 | |
| NO20075628L (no) | Farmasøytiske formuleringer | |
| ITBO20050123A1 (it) | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina | |
| IL185390A (en) | A solid dosage form | |
| EP1984009A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH IMPROVED STABILITY | |
| EP1992348A4 (en) | PHARMACEUTICAL COMBINATION | |
| DK2384754T3 (da) | Farmaceutiske doseringsformer | |
| DE602007010797D1 (de) | Pharmazeutische zusammensetzungen mit rosuvastatin-calcium | |
| RU2398586C3 (ru) | Фармацевтическая композиция | |
| DK1962873T3 (da) | Farmaceutiske sammensætninger omfattende oxalat-reducerende bakterier | |
| EP2172223A4 (en) | COMPOSITION CONTAINING A PHYSIOLOGICALLY ACTIVE SUBSTANCE | |
| BRPI0807078A2 (pt) | Composto, e, formulação farmacêutica | |
| BRPI0616703A2 (pt) | forma de dosagem farmacêutica | |
| ATE493119T1 (de) | Pharmazeutische zusammensetzung | |
| BRPI1009392A2 (pt) | "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica." | |
| DK2001297T3 (da) | Aktivstofkombinationer insekticide egenskaber | |
| EP1987825A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING OSELTAMIVIR PHOSPHATE | |
| PL1850664T3 (pl) | Formulacja kapsułki pestycydowej | |
| ITMI20050729A1 (it) | Nuova formulazione biologicamente attiva | |
| DK1957073T3 (da) | Lægemiddel | |
| EP2193795A4 (en) | AQUEOUS PHARMACEUTICAL COMPOSITION CONTAINING LATANOPROST | |
| ZA200709788B (en) | Cannabinold active pharmaceutical ingredient for Improved dosage forms | |
| DE602008005137D1 (de) | Chinolonverbindung und pharmazeutische zusammensetzung | |
| EP1871347A4 (en) | PHARMACEUTICAL COMPOSITION |